A Phase 2 Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Single Intrathecal Preoperative Administration of AYX1 Injection in Patients Undergoing Unilateral Total Knee Arthroplasty
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Brivoligide (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Adynxx
- 04 Oct 2017 Planned End Date changed from 1 Jan 2018 to 1 Dec 2017.
- 04 Oct 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Oct 2017.
- 04 Oct 2017 According to an Adynxx media release, data from the study are expected in the first quarter of 2018.